Abstract
Hypertension may induce major changes in the arterial intima and media which may lead to arterial injury and atherosclerosis. Although the mechanisms involved in these alterations have not been clearly defined, recent studies in our own and other laboratories have demonstrated changes in gene expression of certain growth factors and functionally important proteins in response to blood pressure elevation or to vasoactive agents. This paper reviews these observations and also summarizes some recent data on the effects of antihypertensive drugs on atherogenesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Geisterfer AAT, Peach MJ, Owens G. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 62: 749–756, 1988.
Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 83: 1419–1424, 1989.
Naftilan AJ, Gilliland GK, Eldridge CS, Karin M, Kraft AS. Induction of the protooncogene c-jun by angiotensin II. Circulation 80: II - 459a, 1989.
Yamori Y, Mano M, Nara Y, Horie R. Catecholamine-induced polyploidization in vascular smooth muscle cells. Circulation 75: I-92-I-95, 1987.
Komuro I, Kurihara H, Sugiyama T, Takaku F, Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Letters 238: 249–252, 1988.
Nemecek GM, Coughlin SR, Handley DA, Moskowitz MA. Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc Natl Acad Sci USA 83: 674–678, 1986.
Sarzani R, Brecher P, Chobanian AV. Growth factor expression in aorta of normotensive and hypertensive rats. J Clin Invest 83: 1404–1408, 1989.
Sporn MB, Roberts AB. Transforming growth factor-B. Multiple actions and potential clinical applications. JAMA 262: 938–941, 1989.
Owens GK, Geisterfer AT, Yang YW, Komoriya A. Transforming growth factor-B-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol 107: 771–780, 1988.
Owens GK, Schwartz SM. Alterations in vascular smooth muscle mass in the spontaneous hypertensive rat. Role in cellular hypertrophy, hyperploidy and hyperplasia. Circ Res 51: 280–289, 1982.
Owens GK, Schwartz SM. Vascular smooth muscle cell hypertrophy and hyperploidy in the Goldblatt hypertensive rat. Circ Res 53: 491–501, 1983.
Lichtenstein AH, Brecher PI, Chobanian AV. Effect of DOC/salt hypertension on cell ploidy in the rat aorta. Hypertension 8: II-50-II54, 1986.
Offner GD, Troxler RF, Brecher P. Characterization of a fatty acid binding protein from rat heart. J Biol Chem 261: 5584–5589, 1986.
Sweetser DA, Heuckeroth RO, Gordon JI. The metabolic significance of mammalian fatty-acid-binding proteins: Abundant proteins in search of a function. Annu Rev Nutr 7: 337–359, 1987.
Bassuk JA, Tsichlis PN, Sorof S. Liver fatty acid binding protein is the mitosis-associated polypeptide target of a carcinogen in rat hepatocytes. Proc Natl Acad Sci (USA) 84: 7547–7551, 1987.
Distel RJ, Ro H-S, Rosen BS, Groves DL, Spiegelman BM. Nucleoprotein complexes that regulate gene expression in adipocyte differentiation: Direct participation of c-fos. Cell 49: 835–844, 1987.
Sarzani R, Claffey KP, Chobanian AV, Brecher P. Hypertension induces tissue-specific gene suppression of a fatty acid binding protein in rat aorta. Proc Natl Acad Sci (USA) 85: 7777–7781, 1988.
Shull GE, Greeb J, Lingrel JB. Molecular cloning of three distinct forms of the Na+,K+-ATPase alpha-subunit from rat brain. Biochemistry 25: 8125–8129, 1986.
Herrera VL, Chobanian AV, Ruiz-Opazo N. Isoform-specific modulation of Na,K-ATPase alpha-subunit gene expression in hypertension. Science 241: 221–223, 1988.
Herrera VL, Ruiz-Opazo N. Identical Na,K-ATPase alpha-1 gene polymorphism in two genetic rat strains. Hypertension 12: 338a, 1988.
Haudenschild CC, Prescott MF, Chobanian AV. Effects of hypertension and its reversal on aortic intimal lesions of the rat. Hypertension 2: 33–44, 1980.
Chobanian AV, Prescott MF, Haudenschild CC. Aortic endothelial changes during the development and reversal of experimental hypertension. In: Gotto A, Smith LC, (eds): Atherosclerosis V. New York: Springer-Verlag, 1980, pp 699–702.
Wiener J, Lattes RG, Meltzer BG, Spiro D. The cellular pathology of experimental hypertension: IV. Evidence for increased vascular permeability. Am J Pathol 54: 187–207, 1969.
Huttner I, Boutet M, Rona G, More RH. Studies of protein passage through arterial endothelium: III. Effect of blood pressure levels on the passage of fine structure protein tracers through rat arterial endothelium. Lab Invest 29: 536–546, 1973.
Chobanian AV, Brecher PI, Haudenschild CC. Effects of hypertension and antihypertensive therapy on atherosclerosis. Hypertension 8: I-15-I-21, 1986.
Vanhoutte, PM. Endothelium and control of vascular function. Hypertension 13: 658–667, 1989.
Chobanian AV, Lichtenstein AH, Nilakhe V, Haudenschild CC, Drago R, Nickerson C. Influence of hypertension on aortic atherosclerosis in the Watanabe rabbit. Hypertension 14: 203–209, 1989.
Chobanian AV, Brecher P, Chan C. Effects of propranolol on atherogenesis in the cholesterol-fed rabbit. Circ Res 56: 755–762, 1985.
Kaplan JR, Manuck SB, Adams MR, Weingand KW, Clarkson TB. Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet. Circulation 76: 1364–1372, 1987.
Henry PD, Bentley KI. Suppression of atherosclerosis in cholesterol-fed rabbits treated with nifedipine. J Clin Invest 68: 1366–1369, 1981.
Chobanian AV. Effects of calcium channel antagonists and other antihypertensive drugs on atherogenesis. J Hypert 5: S43 - S48, 1987.
Lichtenstein AH, Drago R, Nickerson C, Prescott MF, Lee SQ, Chobanian AV. Effect of propranolol on atherogenesis in the Watanabe heritable hyperlipidemic rabbit. J Vasc Med Biol 1: 248–254, 1989.
Van Niekerk JLM, Hendriks Th, DeBoer HHM, Van’t Laar A. Does nifedipine suppress atherogenesis in WHHL rabbits? Atherosclerosis 53: 91–98, 1984.
Tilton GD, Buja LM, Bilheimer DW, Apprill P, Ashton J, McNatt J, Kita T, Willerson JT. Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the Watanabe heritable hyperlipidemic rabbit: an animal model of familial hypercholesterolemia. J Amer Coll Cardiol 6: 141–144, 1985.
Chobanian AV, Haudenschild CC, Nickerson C, Drago R. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension, 15: 327–331, 1990.
Powell JS, Clozel J-P, Muller RKM, Kuhn H, Hefti F, Hosang M, Baumgartner HR. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245: 186–188, 1989.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Chobanian, A.V. (1991). Effects of Hypertension on Arterial Gene Expression and Atherosclerosis. In: Cox, R.H. (eds) Cellular and Molecular Mechanisms in Hypertension. Advances in Experimental Medicine and Biology, vol 308. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-6015-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-6015-5_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-6017-9
Online ISBN: 978-1-4684-6015-5
eBook Packages: Springer Book Archive